{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:14:54Z","timestamp":1788052494426,"version":"build-2784847793"},"reference-count":246,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119156","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:16:45Z","timestamp":1784204205000},"page":"119156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Melatonin hybrids as multifunctional therapeutic agents: A comprehensive review"],"prefix":"10.1016","volume":"318","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9667-8195","authenticated-orcid":false,"given":"Elham Khayer","family":"Damirchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5299-6044","authenticated-orcid":false,"given":"Amin","family":"barani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7273-8306","authenticated-orcid":false,"given":"Seyyed Mohammad","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8769-9912","authenticated-orcid":false,"given":"Mohammad Ali","family":"Ebrahimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ejmech.2026.119156_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127514","article-title":"Structural hybridization as a facile approach to new drug candidates","volume":"30","author":"Sampath Kumar","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119156_bib2","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1021\/jm00089a001","article-title":"The role of concepts in structure-activity relationship studies of opioid ligands","volume":"35","author":"Portoghese","year":"1992","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119156_bib3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2174\/138955710791608280","article-title":"Recent progress in the development of synthetic hybrids of natural or unnatural bioactive compounds for medicinal chemistry","volume":"10","author":"Tsogoeva","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.32947\/ajps.v24i1.1006","article-title":"In Silico prediction of binding affinities of hybrid molecules of benzothiazole cross-linked with Hydroxamic acid by certain linkers","volume":"24","year":"2024","journal-title":"Al Mustansiriyah Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ejmech.2026.119156_bib5","author":"Hargittai"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0960-0760(94)90004-3","article-title":"Bivalent ligands as probes of estrogen receptor action","volume":"49","author":"Bergmann","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119156_bib7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1517\/13543776.18.10.1191","article-title":"Patent issues relating to hybrid drugs","volume":"18","author":"Richards","year":"2008","journal-title":"Expert Opin. Ther. Pat."},{"issue":"19","key":"10.1016\/j.ejmech.2026.119156_bib8","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.2174\/092986710791233689","article-title":"Clinical uses of melatonin: evaluation of human trials","volume":"17","author":"S\u00e1nchez-Barcel\u00f3","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-079X.1993.tb00511.x","article-title":"Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization","volume":"15","author":"Menendez-Pelaez","year":"1993","journal-title":"J. Pineal Res."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10409230903044914","article-title":"Reducing oxidative\/nitrosative stress: a newly-discovered genre for melatonin","volume":"44","author":"Reiter","year":"2009","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1600-079X.2003.00092.x","article-title":"Regulation of antioxidant enzymes: a significant role for melatonin","volume":"36","author":"Rodriguez","year":"2004","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejmech.2026.119156_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","article-title":"MT1 and MT2 melatonin receptors: a therapeutic perspective","volume":"56","author":"Liu","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/biof.23","article-title":"Melatonin: signaling mechanisms of a pleiotropic agent","volume":"35","author":"Hardeland","year":"2009","journal-title":"Biofactors"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/pr.110.002832","article-title":"International Union of basic and clinical pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors","volume":"62","author":"Dubocovich","year":"2010","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib15","first-page":"13","article-title":"Melatonin and aging: prospects for human treatment","volume":"62","author":"Bubenik","year":"2011","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119156_bib16","series-title":"Design of Hybrid Molecules for Drug Development","first-page":"5","article-title":"Multitarget-directed antioxidants as therapeutic agents: putting the focus on the oxidative stress","author":"Ismaili","year":"2017"},{"key":"10.1016\/j.ejmech.2026.119156_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40261-015-0368-5","article-title":"The safety of melatonin in humans","volume":"36","author":"Andersen","year":"2016","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ejmech.2026.119156_bib18","first-page":"1469","article-title":"Synthesis, spectroscopic characterization and antimicrobial studies of Mn(II), Co(II), Ni(II), Cr(III) and Fe(III) melatonin drug complexes","volume":"63","author":"Al-Wasidi","year":"2020","journal-title":"Egypt. J. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cbpa.2009.04.619","article-title":"Alzheimer's disease: new approaches to drug discovery","volume":"13","author":"Bolognesi","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tips.2004.11.007","article-title":"Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders","volume":"26","author":"Youdim","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"issue":"Suppl","key":"10.1016\/j.ejmech.2026.119156_bib21","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2011.02.004","article-title":"2011 Alzheimer's disease facts and figures","volume":"7","year":"2011","journal-title":"Alzheimer's Dement."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119156_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2174\/1385272823666191021124443","article-title":"Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases","volume":"18","author":"Gontijo","year":"2020","journal-title":"Curr. Neuropharmacol."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119156_bib24","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.2174\/156802611798184409","article-title":"Hybrid-based multi-target ligands for the treatment of alzheimer's disease","volume":"11","author":"Rampa","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"issue":"12 Pt 2","key":"10.1016\/j.ejmech.2026.119156_bib25","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1301\/nr.2007.dec.S239-S243","article-title":"Developing preventive therapies for chronic diseases: lessons learned from Alzheimer's disease","volume":"65","author":"Selkoe","year":"2007","journal-title":"Nutr. Rev."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119156_bib26","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1212\/01.WNL.0000140626.48118.0A","article-title":"A focus on the synapse for neuroprotection in Alzheimer disease and other dementias","volume":"63","author":"Coleman","year":"2004","journal-title":"Neurology"},{"issue":"12 Suppl 3","key":"10.1016\/j.ejmech.2026.119156_bib27","first-page":"S34","article-title":"Diagnosis and treatment of Alzheimer's disease","volume":"64","author":"Desai","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"issue":"47","key":"10.1016\/j.ejmech.2026.119156_bib30","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2026.119156_bib31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/gps.935","article-title":"Cholinergic function and Alzheimer's disease","volume":"18","author":"Giacobini","year":"2003","journal-title":"Int. J. Geriatr. Psychiatr."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119156_bib32","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1185\/030079905X65655","article-title":"Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease","volume":"21","author":"Bartorelli","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000008243","article-title":"A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease","volume":"44","author":"Farlow","year":"2000","journal-title":"Eur. Neurol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Bu\u00e9e","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"issue":"16","key":"10.1016\/j.ejmech.2026.119156_bib35","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1073\/pnas.86.16.6338","article-title":"The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid","volume":"86","author":"Palmert","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.ejmech.2026.119156_bib36","doi-asserted-by":"crossref","first-page":"8378","DOI":"10.1073\/pnas.91.18.8378","article-title":"Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging","volume":"91","author":"N\u00e4slund","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"17","key":"10.1016\/j.ejmech.2026.119156_bib37","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/cbic.200700427","article-title":"Insight into the kinetic of amyloid \u03b2 (1\u201342) peptide Self\u2010Aggregation: elucidation of inhibitors' mechanism of action","volume":"8","author":"Bartolini","year":"2007","journal-title":"Chembiochem"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000100355","article-title":"Amyloid-\u03b2 aggregation","volume":"4","author":"Finder","year":"2007","journal-title":"Neurodegener. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/156802607779318262","article-title":"Disrupting \u03b2-amyloid aggregation for Alzheimer disease treatment","volume":"7","author":"Estrada","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"issue":"5580","key":"10.1016\/j.ejmech.2026.119156_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"science"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119156_bib41","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2174\/1567205016666190228122956","article-title":"Donepezil derivatives targeting amyloid-\u03b2 cascade in Alzheimer's disease","volume":"16","author":"Mezeiova","year":"2019","journal-title":"Curr. Alzheimer Res."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119156_bib42","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/cmdc.200800414","article-title":"Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties","volume":"4","author":"Fern\u00e1ndez-Bachiller","year":"2009","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/jm050746d","article-title":"Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties","volume":"49","author":"Rodr\u00edguez-Franco","year":"2006","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2026.119156_bib44","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1016\/j.bmc.2011.09.040","article-title":"Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease","volume":"19","author":"Jiang","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2026.119156_bib45","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/cmdc.201800196","article-title":"Oxoisoaporphine alkaloids: prospective anti-alzheimer's disease, anticancer, and antidepressant agents","volume":"13","author":"Zhang","year":"2018","journal-title":"ChemMedChem"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/jpi.12006","article-title":"Highly selective inhibition of butyrylcholinesterase by a novel melatonin-tacrine heterodimers","volume":"54","author":"Zawadzka","year":"2013","journal-title":"J. Pineal Res."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119156_bib47","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1089\/ars.2012.4671","article-title":"The microglial \u03b17-acetylcholine nicotinic receptor is a key element in promoting neuroprotection by inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2","volume":"19","author":"Parada","year":"2013","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119156_bib48","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1021\/jm5000613","article-title":"New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease","volume":"57","author":"L\u00f3pez-Iglesias","year":"2014","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119156_bib49","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1021\/acschemneuro.5b00082","article-title":"Curcumin\/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP\/PS1 mouse model","volume":"6","author":"Gerenu","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119156_bib50","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1021\/cn500081s","article-title":"Discovery of 5-(4-Hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-Methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for alzheimer's disease by hybridization of curcumin and Melatonin","volume":"5","author":"Chojnacki","year":"2014","journal-title":"ACS Chem. Neurosci."},{"issue":"15","key":"10.1016\/j.ejmech.2026.119156_bib51","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.4155\/fmc.15.99","article-title":"New melatonin-cinnamate hybrids as multi-target drugs for neurodegenerative diseases: Nrf2-induction, antioxidant effect and neuroprotection","volume":"7","author":"Buendia","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119156_bib52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2013.05.045","article-title":"How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo","volume":"66","author":"Forman","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/nen.0b013e31802d6da9","article-title":"Expression of Nrf2 in neurodegenerative diseases","volume":"66","author":"Ramsey","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119156_bib54","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/bph.13025","article-title":"Melatonin-sulforaphane hybrid ITH12674 induces neuroprotection in oxidative stress conditions by a 'drug-prodrug' mechanism of action","volume":"172","author":"Egea","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/13506129.2012.751367","article-title":"Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model","volume":"20","author":"Kim","year":"2013","journal-title":"Amyloid"},{"key":"10.1016\/j.ejmech.2026.119156_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuro.2013.03.004","article-title":"Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease","volume":"36","author":"Morroni","year":"2013","journal-title":"Neurotoxicology"},{"issue":"7113","key":"10.1016\/j.ejmech.2026.119156_bib57","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.ejmech.2026.119156_bib58","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1016\/j.bmc.2016.07.025","article-title":"Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin","volume":"24","author":"Wang","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2026.119156_bib59","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1021\/acs.jmedchem.6b01178","article-title":"The antioxidant additive approach for Alzheimer's Disease therapy: new ferulic (Lipoic) acid plus Melatonin modified tacrines as cholinesterases inhibitors, direct antioxidants, and nuclear factor (Erythroid-Derived 2)-Like 2 activators","volume":"59","author":"Benchekroun","year":"2016","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119156_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800194","article-title":"Donepezil-melatonin hybrids as butyrylcholinesterase inhibitors: improving binding affinity through varying mode of linking fragments","volume":"351","author":"\u0141ozi\u0144ska","year":"2018","journal-title":"Arch. Pharm."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib61","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14756366.2018.1545766","article-title":"Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy","volume":"34","author":"Pach\u00f3n-Angona","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119156_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103205","article-title":"Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer's disease therapy","volume":"91","author":"Malek","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119156_bib63","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1021\/acs.jmedchem.0c01940","article-title":"Melatonin- and ferulic acid-based HDAC6 selective inhibitors exhibit pronounced immunomodulatory effects in vitro and neuroprotective effects in a pharmacological Alzheimer's Disease mouse model","volume":"64","author":"He","year":"2021","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.ejmech.2026.119156_bib64","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.jmedchem.9b01012","article-title":"Highly selective butyrylcholinesterase inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an Alzheimer's Disease mouse model","volume":"62","author":"Hoffmann","year":"2019","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119156_bib65","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1021\/acs.jmedchem.5b01674","article-title":"Discovery of highly selective and nanomolar carbamate-based butyrylcholinesterase inhibitors by rational investigation into their inhibition mode","volume":"59","author":"Sawatzky","year":"2016","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119156_bib66","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1021\/ml3001825","article-title":"Neuroprotective Tri- and tetracyclic BChE inhibitors releasing reversible inhibitors upon carbamate transfer","volume":"3","author":"Darras","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.ejmech.2026.119156_bib67","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.1021\/acs.jmedchem.1c00534","article-title":"Selective pseudo-irreversible butyrylcholinesterase inhibitors transferring antioxidant moieties to the enzyme show pronounced neuroprotective efficacy in vitro and in vivo in an Alzheimer's Disease mouse model","volume":"64","author":"Scheiner","year":"2021","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2026.119156_bib68","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1038\/npp.2017.8","article-title":"Intranasal lactoferrin enhances \u03b1-Secretase-Dependent amyloid precursor protein processing via the ERK1\/2-CREB and HIF-1\u03b1 pathways in an Alzheimer's Disease mouse model","volume":"42","author":"Guo","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2026.119156_bib69","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.redox.2017.11.001","article-title":"\u03b1-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice","volume":"14","author":"Zhang","year":"2018","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1034\/j.1600-079X.2003.00058.x","article-title":"Melatonin prevents free radical formation due to the interaction between beta-amyloid peptides and metal ions [Al(III), Zn(II), Cu(II), Mn(II), Fe(II)]","volume":"35","author":"Zatta","year":"2003","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12502","article-title":"Copper chelators promote nonamyloidogenic processing of A\u03b2PP via MT1\/2\/CREB-dependent signaling pathways in A\u03b2PP\/PS1 transgenic mice","volume":"65","author":"Wang","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejmech.2026.119156_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106100","article-title":"Novel melatonin-trientine conjugate as potential therapeutic agents for Alzheimer's disease","volume":"128","author":"Li","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119156_bib73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.21037\/atm-22-730","article-title":"Design, synthesis, and evaluation of 8-aminoquinoline-melatonin derivatives as effective multifunctional agents for Alzheimer's disease","volume":"10","author":"Chen","year":"2022","journal-title":"Ann. Transl. Med."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2026.119156_bib74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0166-4328(97)86040-8","article-title":"Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease","volume":"83","author":"Robbins","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2026.119156_bib75","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0079-6123(08)62391-2","article-title":"Structure and functions of acetylcholinesterase and butyrylcholinesterase","volume":"98","author":"Massouli\u00e9","year":"1993","journal-title":"Prog. Brain Res."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib76","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","article-title":"Changes in brain cholinesterases in senile dementia of Alzheimer type","volume":"4","author":"Perry","year":"1978","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib77","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02815095","article-title":"Ultrastructural localization of butyrylcholinesterase in senile plaques in the brains of aged and Alzheimer disease patients","volume":"30","author":"G\u00f3mez-Ramos","year":"1997","journal-title":"Mol. Chem. Neuropathol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib78","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/msj.20159","article-title":"Transgenic mouse models of Alzheimer's disease","volume":"77","author":"Elder","year":"2010","journal-title":"Mt. Sinai J. Med."},{"issue":"14","key":"10.1016\/j.ejmech.2026.119156_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24142568","article-title":"Discovery of new selective butyrylcholinesterase (BChE) inhibitors with Anti-A\u03b2 aggregation activity: Structure-Based virtual screening, hit optimization and biological evaluation","volume":"24","author":"Jiang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119156_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115991","article-title":"Novel arylcarbamate-N-acylhydrazones derivatives as promising BuChE inhibitors: design, synthesis, molecular modeling and biological evaluation","volume":"32","author":"Yamazaki","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119156_bib81","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbr.2015.08.026","article-title":"Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse","volume":"296","author":"Maurice","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib82","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2026.119156_bib83","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.brainres.2005.04.011","article-title":"Melatonin improves learning and memory performances impaired by hyperhomocysteinemia in rats","volume":"1046","author":"Baydas","year":"2005","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01190","article-title":"Role of immune-pineal axis in neurodegenerative diseases, unraveling novel hybrid dark hormone therapies","volume":"5","author":"Beriwal","year":"2019","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119156_bib85","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1021\/acsami.9b22214","article-title":"Near-Infrared responsive Dopamine\/Melatonin-Derived nanocomposites abrogating in situ amyloid \u03b2 nucleation, propagation, and ameliorate neuronal functions","volume":"12","author":"Srivastava","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib86","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12929-017-0355-7","article-title":"Drug candidates in clinical trials for Alzheimer's disease","volume":"24","author":"Hung","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejmech.2026.119156_bib87","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejmech.2016.05.055","article-title":"New cinnamic - N-benzylpiperidine and cinnamic - n,n-dibenzyl(n-methyl)amine hybrids as alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and neurogenic properties","volume":"121","author":"Estrada","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119156_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117146","article-title":"Dual functional antioxidant and butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease: design, synthesis and evaluation of novel melatonin-alkylbenzylamine hybrids","volume":"78","author":"Liu","year":"2023","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119156_bib89","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119156_bib90","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jalz.2014.08.104","article-title":"Self-reported sleep disturbance is associated with Alzheimer's disease risk in men","volume":"11","author":"Benedict","year":"2015","journal-title":"Alzheimer's Dement."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031867","article-title":"Protective effect of the novel Melatonin analogue containing donepezil fragment on memory impairment via MT\/ERK\/CREB signaling in the hippocampus in a rat model of pinealectomy and subsequent A\u03b2(1-42) infusion","volume":"25","author":"Tchekalarova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib92","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/bjc.1989.272","article-title":"Growth inhibitory and cytotoxic effects of melatonin and its metabolites on human tumour cell lines in vitro","volume":"60","author":"Shellard","year":"1989","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib93","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3390\/ijms14022410","article-title":"Melatonin anticancer effects: review","volume":"14","author":"Di Bella","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119156_bib94","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.neo.7900203","article-title":"TRAIL\/Apo-2L: mechanisms and clinical applications in cancer","volume":"3","author":"Srivastava","year":"2001","journal-title":"Neoplasia"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119156_bib95","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.18632\/oncotarget.2994","article-title":"12\/15 Lipoxygenase regulation of colorectal tumorigenesis is determined by the relative tumor levels of its metabolite 12-HETE and 13-HODE in animal models","volume":"6","author":"Chang","year":"2015","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.ejmech.2026.119156_bib96","first-page":"4693","article-title":"Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events","volume":"59","author":"Blask","year":"1999","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119156_bib97","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/sj.mp.4001593","article-title":"Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor","volume":"10","author":"Thomson","year":"2005","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib98","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s13197-013-1221-6","article-title":"Quantitative determination of melatonin in milk by LC-MS\/MS","volume":"51","author":"Karunanithi","year":"2014","journal-title":"J. Food Sci. Technol."},{"issue":"36","key":"10.1016\/j.ejmech.2026.119156_bib99","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.2174\/092986710794183015","article-title":"Basic mechanisms involved in the anti-cancer effects of melatonin","volume":"17","author":"Mediavilla","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119156_bib100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.sleep.2006.11.010","article-title":"Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease","volume":"8","author":"Wu","year":"2007","journal-title":"Sleep Med."},{"key":"10.1016\/j.ejmech.2026.119156_bib101","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1743-7075-2-22","article-title":"Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug","volume":"2","author":"Hardeland","year":"2005","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.ejmech.2026.119156_bib102","doi-asserted-by":"crossref","DOI":"10.11131\/2015\/101185","article-title":"Retinoic acid-related orphan receptors (RORs): regulatory functions in immunity, development, Circadian Rhythm, and metabolism","volume":"2","author":"Cook","year":"2015","journal-title":"Nucl. Recept. Res."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib103","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/jpi.12010","article-title":"On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK","volume":"54","author":"Galano","year":"2013","journal-title":"J. Pineal Res."},{"issue":"5\u20136","key":"10.1016\/j.ejmech.2026.119156_bib104","doi-asserted-by":"crossref","first-page":"209","DOI":"10.18632\/genesandcancer.107","article-title":"Melatonin decreases estrogen receptor binding to estrogen response elements sites on the OCT4 gene in human breast cancer stem cells","volume":"7","author":"Lopes","year":"2016","journal-title":"Genes Cancer"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119156_bib105","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.bjc.6605336","article-title":"Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells","volume":"101","author":"Mart\u00ednez-Campa","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib106","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1034\/j.1600-079X.2003.00077.x","article-title":"Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro","volume":"35","author":"Leon-Blanco","year":"2003","journal-title":"J. Pineal Res."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib107","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1568026023394335","article-title":"Melatonin-immune system relationships","volume":"2","author":"Guerrero","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib108","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.3390\/ijms14048638","article-title":"Melatonin: buffering the immune system","volume":"14","author":"Carrillo-Vico","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2009.09.005","article-title":"The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control","volume":"79","author":"Campbell","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0024-3205(99)00262-3","article-title":"Melatonin increases p53 and p21WAFl expression in MCF-7 human breast cancer cells in vitro","volume":"65","author":"Mediavilla","year":"1999","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib111","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11670-012-0269-6","article-title":"Melatonin inhibits the expression of vascular endothelial growth factor in pancreatic cancer cells","volume":"24","author":"Lv","year":"2012","journal-title":"Chin. J. Cancer Res."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119156_bib112","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.archoralbio.2011.03.004","article-title":"A new perspective in oral health: potential importance and actions of melatonin receptors MT1, MT2, MT3, and RZR\/ROR in the oral cavity","volume":"56","author":"Cutando","year":"2011","journal-title":"Arch. Oral Biol."},{"issue":"11\u201312","key":"10.1016\/j.ejmech.2026.119156_bib113","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/1947601913479022","article-title":"Cyclins and cell cycle control in cancer and disease","volume":"3","author":"Casimiro","year":"2012","journal-title":"Genes Cancer"},{"issue":"Pt 3","key":"10.1016\/j.ejmech.2026.119156_bib114","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1469-7793.2001.0581h.x","article-title":"Amine uptake and peptide hormone secretion: APUD cells in a new landscape","volume":"531","author":"Boyd","year":"2001","journal-title":"J. Physiol."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119156_bib115","first-page":"15","article-title":"[Clinical pathology of the APUD system (apudopathy)]","volume":"56","author":"Kvetno\u012d","year":"1978","journal-title":"Klin. Med. (Mosc.)"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119156_bib116","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1021\/jm401343c","article-title":"MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential","volume":"57","author":"Zlotos","year":"2014","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib117","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/acs.chemrestox.8b00216","article-title":"Design, synthesis, and biological activity of hydrogen Peroxide Responsive Arylboronate Melatonin hybrids","volume":"32","author":"Bedini","year":"2019","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib118","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib119","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1186\/s12885-020-07582-x","article-title":"Long-term trends in colorectal cancer: incidence, localization, and presentation","volume":"20","author":"H\u00f8ydahl","year":"2020","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119156_bib120","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem. Rev."},{"issue":"13","key":"10.1016\/j.ejmech.2026.119156_bib121","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2174\/1871520620999201124212840","article-title":"Chalcone scaffolds as anticancer drugs: a review on molecular Insight in action of mechanisms and anticancer properties","volume":"21","author":"Shukla","year":"2021","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119156_bib122","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1007\/s13277-014-2289-y","article-title":"Benzylidenetetralones, cyclic chalcone analogues, induce cell cycle arrest and apoptosis in HCT116 colorectal cancer cells","volume":"35","author":"Drutovic","year":"2014","journal-title":"Tumour Biol"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119156_bib123","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1039\/C8MD00284C","article-title":"Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer in vitro and in vivo","volume":"9","author":"Lu","year":"2018","journal-title":"Medchemcomm"},{"issue":"22","key":"10.1016\/j.ejmech.2026.119156_bib124","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1016\/j.bmc.2013.09.014","article-title":"Benzochalcones bearing pyrazoline moieties show anti-colorectal cancer activities and selective inhibitory effects on aurora kinases","volume":"21","author":"Shin","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119156_bib125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.lfs.2016.02.073","article-title":"Chalcone derivatives cause accumulation of colon cancer cells in the G2\/M phase and induce apoptosis","volume":"150","author":"Kello","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2026.119156_bib126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00044-021-02805-7","article-title":"New class of hybrids based on chalcone and melatonin: a promising therapeutic option for the treatment of colorectal cancer","volume":"30","author":"Yepes","year":"2021","journal-title":"Med. Chem. Res."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib127","first-page":"241","article-title":"Down-regulation of HOXA4, HOXA7, HOXA10, HOXA11 and MEIS1 during monocyte-macrophage differentiation in THP-1 cells","volume":"2","author":"Martino","year":"2009","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2026.119156_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118934","article-title":"Therapeutic targets of cancer drugs: modulation by melatonin","volume":"267","author":"Moloudizargari","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2026.119156_bib129","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920931714","article-title":"The role of melatonin in colorectal cancer treatment: a comprehensive review","volume":"12","author":"Kvietkauskas","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ejmech.2026.119156_bib130","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9740568","article-title":"Therapeutic opportunities in colorectal cancer: focus on melatonin antioncogenic action","volume":"2019","author":"Wu","year":"2019","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejmech.2026.119156_bib131","article-title":"The potential therapeutic actions of melatonin in colorectal cancer","volume":"39","author":"Chok","year":"2019","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"issue":"19","key":"10.1016\/j.ejmech.2026.119156_bib132","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2174\/1568026619666190619115735","article-title":"Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases","volume":"19","author":"Ivasiv","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119156_bib133","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2174\/1568026616666160927155515","article-title":"Hybrid compounds as multitarget directed anticancer agents","volume":"17","author":"Kucuksayan","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119156_bib134","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1517\/17460441.2013.798296","article-title":"Advances in the development of hybrid anticancer drugs","volume":"8","author":"Fortin","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119156_bib135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2017.07.033","article-title":"Recent advances (2015-2016) in anticancer hybrids","volume":"142","author":"Kerru","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040843","article-title":"Melatonin, a full service anti-cancer agent: inhibition of initiation, progression and metastasis","volume":"18","author":"Reiter","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.ejmech.2026.119156_bib137","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1523\/JNEUROSCI.21-16-06405.2001","article-title":"Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor","volume":"21","author":"Brainard","year":"2001","journal-title":"J. Neurosci."},{"issue":"20","key":"10.1016\/j.ejmech.2026.119156_bib138","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/jnci\/93.20.1557","article-title":"Night shift work, light at night, and risk of breast cancer","volume":"93","author":"Davis","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"20","key":"10.1016\/j.ejmech.2026.119156_bib139","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/jnci\/93.20.1563","article-title":"Rotating night shifts and risk of breast cancer in women participating in the nurses' health study","volume":"93","author":"Schernhammer","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119156_bib140","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.gyobfe.2015.10.004","article-title":"[Night work, shift work: breast cancer risk factor?]","volume":"43","author":"Benabu","year":"2015","journal-title":"Gynecol. Obstet. Fertil."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib141","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jcb.22185","article-title":"Histone deacetylase inhibitors: potential in cancer therapy","volume":"107","author":"Marks","year":"2009","journal-title":"J. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119156_bib142","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300149","article-title":"Melatonin-vorinostat hybrid ligands show higher histone deacetylase and cancer cell growth inhibition than vorinostat","volume":"356","author":"Helmi","year":"2023","journal-title":"Arch. Pharm."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119156_bib143","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"13","key":"10.1016\/j.ejmech.2026.119156_bib144","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1021\/acs.jmedchem.1c00629","article-title":"Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation","volume":"64","author":"Dong","year":"2021","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119156_bib145","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/np50023a014","article-title":"Plant anticancer agents. XII. Isolation and structure elucidation of new cytotoxic quinones from Tabebuia cassinoides","volume":"45","author":"Rao","year":"1982","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.119156_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106541","article-title":"Design, synthesis, and biological evaluation of novel napabucasin-melatonin hybrids as potent STAT3 inhibitors","volume":"136","author":"Zhang","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057941","article-title":"New role of JAK2\/STAT3 signaling in endothelial cell oxidative stress injury and protective effect of melatonin","volume":"8","author":"Duan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119156_bib148","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejmech.2015.08.054","article-title":"Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitors","volume":"103","author":"Pallandre","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119156_bib149","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00044-024-03279-z","article-title":"A potent therapeutic scaffold fusing quinazolinone\/melatonin for future colorectal cancer interventions: design, one-pot synthesis, biological and ADME-tox modeling studies","volume":"33","author":"Preciado","year":"2024","journal-title":"Med. Chem. Res."},{"issue":"23","key":"10.1016\/j.ejmech.2026.119156_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311403","article-title":"Antitumor activity of metformin in combination with binimetinib against Melanoma cells","volume":"26","author":"Wolan","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2026.119156_bib151","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11010-019-03617-5","article-title":"Melatonin and its ubiquitous anticancer effects","volume":"462","author":"Bhattacharya","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2026.119156_bib152","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1749-6632.1994.tb21831.x","article-title":"Melatonin--a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro","volume":"738","author":"Poeggeler","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2026.119156_bib153","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3835(93)90076-L","article-title":"The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo","volume":"70","author":"Tan","year":"1993","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib154","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0891-5849(96)00046-9","article-title":"Evaluation of the antioxidant activity of melatonin in vitro","volume":"21","author":"Marshall","year":"1996","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119156_bib155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10540-007-9052-1","article-title":"Melatonin: new places in therapy","volume":"27","author":"Maharaj","year":"2007","journal-title":"Biosci. Rep."},{"issue":"15","key":"10.1016\/j.ejmech.2026.119156_bib156","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119156_bib157","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/pcp\/pce081","article-title":"Lipoic acid metabolism in Arabidopsis thaliana: cloning and characterization of a cDNA encoding lipoyltransferase","volume":"42","author":"Wada","year":"2001","journal-title":"Plant Cell Physiol."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119156_bib158","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00011-017-1079-6","article-title":"Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential","volume":"66","author":"Tibullo","year":"2017","journal-title":"Inflamm. Res."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2026.119156_bib159","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0891-5849(96)00269-9","article-title":"Neuroprotection by the metabolic antioxidant alpha-lipoic acid","volume":"22","author":"Packer","year":"1997","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0895-7061(02)03253-3","article-title":"Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production","volume":"16","author":"Midaoui","year":"2003","journal-title":"Am. J. Hypertens."},{"issue":"18","key":"10.1016\/j.ejmech.2026.119156_bib161","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1016\/j.bmc.2006.05.042","article-title":"Synthesis, pulse radiolysis, and in vitro radioprotection studies of melatoninolipoamide, a novel conjugate of melatonin and alpha-lipoic acid","volume":"14","author":"Venkatachalam","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119156_bib162","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1749-6632.1994.tb12079.x","article-title":"The potent free radical scavenger alpha-lipoic acid improves cognition in rodents","volume":"717","author":"Stoll","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib163","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1600-0676.2002.01682.x","article-title":"Inhibition of glucose production and stimulation of bile flow by R (+)-alpha-lipoic acid enantiomer in rat liver","volume":"22","author":"Anderwald","year":"2002","journal-title":"Liver"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119156_bib164","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acschemneuro.5b00041","article-title":"Neurogenic potential assessment and pharmacological characterization of 6-Methoxy-1,2,3,4-tetrahydro-\u03b2-carboline (Pinoline) and Melatonin-Pinoline hybrids","volume":"6","author":"de la Fuente Revenga","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib165","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0891-5849(92)90184-I","article-title":"Antioxidant potential of ferulic acid","volume":"13","author":"Graf","year":"1992","journal-title":"Free Radic. Biol. Med."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119156_bib166","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41419-018-0888-z","article-title":"Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity","volume":"9","author":"Kim","year":"2018","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib167","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s10517-017-3800-4","article-title":"Antioxidant and antiamnestic effects of potassium comenate and comenic acid under conditions of normobaric Hypoxia with Hypercapnia","volume":"163","author":"Shurygina","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"issue":"24","key":"10.1016\/j.ejmech.2026.119156_bib168","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.4155\/fmc-2019-0191","article-title":"Synthesis of new ferulic\/lipoic\/comenic acid-melatonin hybrids as antioxidants and Nrf2 activators via Ugi reaction","volume":"11","author":"Pach\u00f3n-Angona","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119156_bib169","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.plipres.2018.04.004","article-title":"A global perspective on carotenoids: metabolism, biotechnology, and benefits for nutrition and health","volume":"70","author":"Rodriguez-Concepcion","year":"2018","journal-title":"Prog. Lipid Res."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.clindermatol.2008.01.011","article-title":"Lutein and zeaxanthin in eye and skin health","volume":"27","author":"Roberts","year":"2009","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.ejmech.2026.119156_bib171","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fnagi.2017.00254","article-title":"Effects of Lutein\/Zeaxanthin supplementation on the cognitive function of community dwelling older adults: a randomized, Double-Masked, placebo-controlled trial","volume":"9","author":"Hammond","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119156_bib172","doi-asserted-by":"crossref","DOI":"10.3390\/nu9111246","article-title":"Effects of a lutein and Zeaxanthin intervention on cognitive function: a randomized, Double-Masked, placebo-controlled trial of younger healthy adults","volume":"9","author":"Renzi-Hammond","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2026.119156_bib173","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.preteyeres.2015.10.003","article-title":"Lutein, zeaxanthin, and meso-zeaxanthin: the basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease","volume":"50","author":"Bernstein","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119156_bib174","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8090390","article-title":"Zeaxanthin: metabolism, properties, and antioxidant protection of eyes, heart, liver, and skin","volume":"8","author":"Murillo","year":"2019","journal-title":"Antioxidants"},{"issue":"15","key":"10.1016\/j.ejmech.2026.119156_bib175","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154822","article-title":"Synthesis, pharmacokinetic characterization and antioxidant capacity of Carotenoid succinates and their melatonin conjugates","volume":"27","author":"Czett","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib176","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/nutrit\/nuv064","article-title":"Absorption, metabolism, and functions of \u03b2-cryptoxanthin","volume":"74","author":"Burri","year":"2016","journal-title":"Nutr. Rev."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib177","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0883-2897(91)90132-5","article-title":"PET and plasma pharmacokinetic studies after bolus intravenous administration of [11C]melatonin in humans","volume":"18","author":"Le Bars","year":"1991","journal-title":"Int J Rad Appl Instrum B"},{"issue":"21","key":"10.1016\/j.ejmech.2026.119156_bib178","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2174\/092986708785747599","article-title":"Fluorescent GPCR ligands as new tools in pharmacology","volume":"15","author":"Kuder","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119156_bib179","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1478-811X-7-16","article-title":"Illuminating the life of GPCRs","volume":"7","author":"B\u00f6hme","year":"2009","journal-title":"Cell Commun. Signal."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib180","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12551-012-0073-z","article-title":"Contributions of fluorescence techniques to understanding G protein-coupled receptor dimerisation","volume":"4","author":"Goddard","year":"2012","journal-title":"Biophys. Rev."},{"issue":"28","key":"10.1016\/j.ejmech.2026.119156_bib181","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.2174\/092986712803341476","article-title":"Ligands for fluorescence correlation spectroscopy on g protein-coupled receptors","volume":"19","author":"Jakobs","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib182","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/ml4004155","article-title":"Original design of fluorescent ligands by fusing BODIPY and melatonin neurohormone","volume":"5","author":"Thireau","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"issue":"45","key":"10.1016\/j.ejmech.2026.119156_bib183","doi-asserted-by":"crossref","first-page":"14426","DOI":"10.1021\/ja064310e","article-title":"Synthesis of 7-azaserotonin: its photophysical properties associated with excited state proton transfer reaction","volume":"128","author":"Wu","year":"2006","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119156_bib184","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/cmdc.200700043","article-title":"7\u2010azamelatonin: efficient synthetic routes, excited\u2010state double proton transfer properties and biomedical implications","volume":"2","author":"Wu","year":"2007","journal-title":"ChemMedChem: Chemistry Enabling Drug Discovery"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119156_bib185","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1021\/cr078381n","article-title":"BODIPY dyes and their derivatives: syntheses and spectroscopic properties","volume":"107","author":"Loudet","year":"2007","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119156_bib186","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/anie.200702070","article-title":"The chemistry of fluorescent bodipy dyes: versatility unsurpassed","volume":"47","author":"Ulrich","year":"2008","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib187","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1039\/C1CS15132K","article-title":"Fluorescent indicators based on BODIPY","volume":"41","author":"Boens","year":"2012","journal-title":"Chem. Soc. Rev."},{"issue":"23","key":"10.1016\/j.ejmech.2026.119156_bib188","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1016\/j.bmc.2012.09.049","article-title":"Design, synthesis and pharmacological characterization of coumarin-based fluorescent analogs of excitatory amino acid transporter subtype 1 selective inhibitors, UCPH-101 and UCPH-102","volume":"20","author":"Huynh","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib189","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1021\/cb500078u","article-title":"Bright building blocks for chemical biology","volume":"9","author":"Lavis","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119156_bib190","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejmech.2015.09.003","article-title":"New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization","volume":"103","author":"de la Fuente Revenga","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib191","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12975-010-0049-x","article-title":"High and low molecular weight fluorescein isothiocyanate (FITC)-Dextrans to assess blood-brain barrier disruption: technical considerations","volume":"2","author":"Hoffmann","year":"2011","journal-title":"Transl Stroke Res"},{"issue":"24","key":"10.1016\/j.ejmech.2026.119156_bib192","doi-asserted-by":"crossref","first-page":"22190","DOI":"10.1021\/acsomega.3c02518","article-title":"Synthesis and fluorescence properties of 4-Cyano and 4-Formyl melatonin as putative melatoninergic ligands","volume":"8","author":"Bartolucci","year":"2023","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib193","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119156_bib194","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1177\/002215540205001212","article-title":"Expression of P-glycoprotein in human cerebral cortex microvessels","volume":"50","author":"Virgintino","year":"2002","journal-title":"J. Histochem. Cytochem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119156_bib195","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1073\/pnas.71.7.2627","article-title":"Promotion of fluorescence upon binding of colchicine to tubulin","volume":"71","author":"Bhattacharyya","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119156_bib196","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1073\/pnas.74.8.3466","article-title":"Addition of colchicine--tubulin complex to microtubule ends: the mechanism of substoichiometric colchicine poisoning","volume":"74","author":"Margolis","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2026.119156_bib197","unstructured":"Masliah, E. and P. Tone, LABELING OF BRAIN MICROCIRCULATION AFTER SYSTEMIC ADMINISTRATION OF MELATONIN-FLUORESCEIN CONJUGATE IN HEALTHY MICE."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib198","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jsb.2010.06.015","article-title":"A confocal study on the visualization of chromaffin cell secretory vesicles with fluorescent targeted probes and acidic dyes","volume":"172","author":"Moreno","year":"2010","journal-title":"J. Struct. Biol."},{"issue":"13","key":"10.1016\/j.ejmech.2026.119156_bib199","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1016\/j.bmc.2007.03.080","volume":"15","author":"Di Giacomo","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119156_bib200","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd.2017.178","article-title":"Trends in GPCR drug discovery: new agents, targets and indications","volume":"16","author":"Hauser","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.104.000497","article-title":"G protein-coupled receptor dimerization: function and ligand pharmacology","volume":"66","author":"Milligan","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib202","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.113.008052","article-title":"G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives","volume":"66","author":"Ferr\u00e9","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119156_bib203","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000330000","article-title":"History and biological significance of GPCR heteromerization in the neuroendocrine system","volume":"95","author":"Tadagaki","year":"2012","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119156_bib204","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1039\/c4md00079j","article-title":"N1-linked melatonin dimers as bivalent ligands targeting dimeric melatonin receptors","volume":"5","author":"Journ\u00e9","year":"2014","journal-title":"Medchemcomm"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119156_bib205","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/cmdc.201100101","article-title":"Design strategies for bivalent ligands targeting GPCRs","volume":"6","author":"Shonberg","year":"2011","journal-title":"ChemMedChem"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib206","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/157016308786733591","article-title":"Bivalent ligands as specific pharmacological tools for G protein-coupled receptor dimers","volume":"5","author":"Berque-Bestel","year":"2008","journal-title":"Curr. Drug Discov. Technol."},{"issue":"21","key":"10.1016\/j.ejmech.2026.119156_bib207","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.2174\/092986712801323153","article-title":"Recent progress in the development of agonists and antagonists for melatonin receptors","volume":"19","author":"Zlotos","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119156_bib208","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bioorg.2019.01.004","article-title":"O-linked melatonin dimers as bivalent ligands targeting dimeric melatonin receptors","volume":"85","author":"Karamitri","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2026.119156_bib209","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.ejmech.2026.119156_bib210","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1021\/acs.jmedchem.8b00893","article-title":"Identification of bivalent ligands with Melatonin receptor agonist and Fatty Acid Amide Hydrolase (FAAH) inhibitory activity that exhibit ocular hypotensive effect in the rabbit","volume":"61","author":"Spadoni","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib211","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.112.202036","article-title":"Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma","volume":"346","author":"Crooke","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"issue":"26","key":"10.1016\/j.ejmech.2026.119156_bib212","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1021\/jm700957j","article-title":"N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands","volume":"50","author":"Rivara","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119156_bib213","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.biopha.2016.11.106","article-title":"The arguments for and against cannabinoids application in glaucomatous retinopathy","volume":"86","author":"Panahi","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119156_bib214","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"issue":"14","key":"10.1016\/j.ejmech.2026.119156_bib215","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1167\/iovs.16-19437","article-title":"Evidence for a GPR18 role in diurnal regulation of intraocular pressure","volume":"57","author":"Miller","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"18","key":"10.1016\/j.ejmech.2026.119156_bib216","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1021\/acs.jmedchem.5b01066","article-title":"Highly potent and selective MT2 melatonin receptor full agonists from conformational analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines","volume":"58","author":"Spadoni","year":"2015","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119156_bib217","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/cmdc.201200303","article-title":"MT1-selective melatonin receptor ligands: synthesis, pharmacological evaluation, and molecular dynamics investigation of N-{[(3-O-substituted)anilino]alkyl}amides","volume":"7","author":"Rivara","year":"2012","journal-title":"ChemMedChem"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119156_bib218","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1021\/jm021119g","article-title":"Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors","volume":"46","author":"Tarzia","year":"2003","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2026.119156_bib219","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1021\/jm031140x","article-title":"Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies","volume":"47","author":"Mor","year":"2004","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119156_bib220","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1021\/cr300176g","article-title":"Arylglyoxals in synthesis of heterocyclic compounds","volume":"113","author":"Eftekhari-Sis","year":"2013","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib221","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nchem.1798","article-title":"Biogenetically inspired synthesis and skeletal diversification of indole alkaloids","volume":"6","author":"Mizoguchi","year":"2014","journal-title":"Nat. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2026.119156_bib222","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1021\/jo900986z","article-title":"Efficient and diverse synthesis of indole derivatives","volume":"74","author":"Liu","year":"2009","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119156_bib223","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103021","article-title":"Medicinal chemistry of indole derivatives: current to future therapeutic prospectives","volume":"89","author":"Kumari","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"39","key":"10.1016\/j.ejmech.2026.119156_bib224","doi-asserted-by":"crossref","first-page":"27525","DOI":"10.1039\/D3RA05531K","article-title":"Design, synthesis, molecular docking and DFT studies on novel melatonin and isatin based azole derivatives","volume":"13","author":"Saini","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119156_bib225","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","article-title":"Triazole derivatives and their anti-tubercular activity","volume":"138","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119156_bib226","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/1570193X11310010004","article-title":"Synthesis and biological applications of triazole derivatives \u2013 a review","volume":"10","author":"Kumar","year":"2013","journal-title":"Mini-Reviews Org. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119156_bib227","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.chembiol.2007.10.011","article-title":"Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth","volume":"14","author":"Lepesheva","year":"2007","journal-title":"Chem. Biol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119156_bib228","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(04)01043-6","article-title":"The global distribution and population at risk of malaria: past, present, and future","volume":"4","author":"Hay","year":"2004","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119156_bib229","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1365-3156.2005.01476.x","article-title":"Is malaria a disease of poverty? A review of the literature","volume":"10","author":"Worrall","year":"2005","journal-title":"Trop. Med. Int. Health"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119156_bib230","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pt.2012.03.006","article-title":"Systems immunology of human malaria","volume":"28","author":"Tran","year":"2012","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2026.119156_bib231","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2019.02.019","article-title":"Indole based antimalarial compounds targeting the melatonin pathway: their design, synthesis and biological evaluation","volume":"168","author":"Luthra","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119156_bib232","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156652406776055212","article-title":"Immune responses to asexual blood-stages of malaria parasites","volume":"6","author":"Yazdani","year":"2006","journal-title":"Curr. Mol. Med."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119156_bib233","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-079X.2007.00488.x","article-title":"Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection","volume":"43","author":"Guha","year":"2007","journal-title":"J. Pineal Res."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119156_bib234","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1097\/CCM.0b013e318187b863","article-title":"Selective activation of melatonin receptors with ramelteon improves liver function and hepatic perfusion after hemorrhagic shock in rat","volume":"36","author":"Mathes","year":"2008","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbrc.2014.02.070","article-title":"An interplay between 2 signaling pathways: melatonin-camp and IP3-Ca2+ signaling pathways control intraerythrocytic development of the malaria parasite Plasmodium falciparum","volume":"446","author":"Furuyama","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.119156_bib236","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejmech.2014.03.055","article-title":"Synthetic indole and melatonin derivatives exhibit antimalarial activity on the cell cycle of the human malaria parasite Plasmodium falciparum","volume":"78","author":"Schuck","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119156_bib237","first-page":"915","article-title":"Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease","volume":"10","author":"Pineton de Chambrun","year":"2016","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119156_bib238","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2026.119156_bib239","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"issue":"27","key":"10.1016\/j.ejmech.2026.119156_bib240","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119156_bib241","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1166\/jbn.2022.3232","article-title":"Hyaluronic acid-melatonin nanoparticles improve the dysregulated intestinal barrier, microbiome and immune response in mice with Dextran Sodium Sulfate-Induced colitis","volume":"18","author":"Jing","year":"2022","journal-title":"J. Biomed. Nanotechnol."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119156_bib242","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/fsn3.1118","article-title":"Lactobacillus paracasei Jlus66 extenuate oxidative stress and inflammation via regulation of intestinal flora in rats with non alcoholic fatty liver disease","volume":"7","author":"Wang","year":"2019","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.ejmech.2026.119156_bib243","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.anaerobe.2013.03.011","article-title":"Diet, the human gut microbiota, and IBD","volume":"24","author":"Wu","year":"2013","journal-title":"Anaerobe"},{"issue":"36","key":"10.1016\/j.ejmech.2026.119156_bib244","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/aa7c76","article-title":"Nanomelatonin triggers superior anticancer functionality in a human malignant glioblastoma cell line","volume":"28","author":"Kumar Yadav","year":"2017","journal-title":"Nanotechnology"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119156_bib245","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22060904","article-title":"Combined treatment with hyaluronic acid and mesalamine protects rats from inflammatory bowel disease induced by intracolonic administration of trinitrobenzenesulfonic acid","volume":"22","author":"Chiu","year":"2017","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119156_bib246","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.7150\/thno.15710","article-title":"Combination therapy for ulcerative colitis: orally targeted nanoparticles prevent mucosal damage and relieve inflammation","volume":"6","author":"Xiao","year":"2016","journal-title":"Theranostics"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600601X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600601X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:14:46Z","timestamp":1788048886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600601X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":246,"alternative-id":["S022352342600601X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119156","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melatonin hybrids as multifunctional therapeutic agents: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119156"}}